Back
Intellia Therapeutics Vs. Expedia Group Industry Stock Comparison
Sell
37
NTLA
Intellia Therapeutics
Last Price:
24.85
Seasonality Move:
25.41%
Sell
43
EXPE
Expedia Group
Last Price:
110.28
Seasonality Move:
6.08%
Sell
37
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $24.84. The Score for NTLA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Expedia Group (EXPE)
is a Sell
Is Expedia Group a Buy, Sell or Hold?
- The current Expedia Group [EXPE] share price is $110.31. The Score for EXPE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- EXPE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $24.84
The current trend is relatively stagnant and NTLA is experiencing slight selling pressure.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $110.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EXPE is experiencing selling pressure, which indicates risk of future bearish movement.
NTLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.46 | Buy |
Relative Strength Index (14 RSI): | 51.18 | Buy |
Chaikin Money Flow: | -147774 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.89 - 25.71) | Buy |
Bollinger Bands (100): | (23.47 - 28.93) | Sell |
EXPE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.06 | Sell |
Relative Strength Index (14 RSI): | 28.84 | Sell |
Chaikin Money Flow: | -1118804 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.12 - 131.56) | Sell |
Bollinger Bands (100): | (122.94 - 147.14) | Sell |
NTLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.74 | Sell |
20-day SMA: | 24.49 | Buy |
50-day SMA: | 24.6 | Buy |
200-day SMA: | 28.87 | Sell |
8-day EMA: | 25.32 | Sell |
20-day EMA: | 24.79 | Buy |
50-day EMA: | 24.99 | Sell |
200-day EMA: | 29.53 | Sell |
EXPE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.35 | Sell |
20-day SMA: | 117.33 | Sell |
50-day SMA: | 126.95 | Sell |
200-day SMA: | 126.04 | Sell |
8-day EMA: | 112.28 | Sell |
20-day EMA: | 116.74 | Sell |
50-day EMA: | 124.4 | Sell |
200-day EMA: | 126.19 | Sell |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.26 per share, and a decrease next year of $0.37 per share.
Expedia Group Earnings Growth & EXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.46 per share, a decrease next quarter of $2.62 per share, an increase this year of $2.12 per share, and an increase next year of $2.83 per share.
Intellia Therapeutics Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Expedia Group Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |